Korea vs United Arab Emirates: Share of S. aureus infections resistant to methicillin
Korea
45.7%
in 2022
United Arab Emirates
39.9%
in 2022
Korea rank
12th
United Arab Emirates rank
15th
Share of S. aureus infections resistant to methicillin over time
- Korea
- United Arab Emirates
How they compare
Korea currently reports 45.7% against 39.9% in United Arab Emirates, a difference of 5.8%.
That makes Korea's figure about 1.1 times United Arab Emirates's.
Across all 6 years both countries report, Korea has been ahead every year.
Korea ranks 12th and United Arab Emirates ranks 15th of 45 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 49.7% | 31.3% | 18.3% | Korea |
| 2020s | 46.2% | 39.4% | 6.8% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Korea or United Arab Emirates?
- Korea, at 45.7% against 39.9% in United Arab Emirates as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Korea and United Arab Emirates?
- 5.8%, with Korea ahead.
- How many years of comparable data are there for Korea and United Arab Emirates?
- 6 years are reported by both, from 2017 to 2022.
- How do Korea and United Arab Emirates rank globally for share of s. aureus infections resistant to methicillin?
- Korea ranks 12th and United Arab Emirates ranks 15th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).